Lenalidomide after Stem-Cell Transplantation for Multiple MyelomaPhilip L. McCarthy, Charles Linker, Jan S. Moreb et al.|New England Journal of Medicine|2012Cited by 1.1k
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trialDavid Marín, Katayoun Rezvani, Ye Li et al.|Nature Medicine|2024Cited by 452
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Takahashi, Koichi Saeki et al.|Nature Genetics|2025Cited by 10
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Takahashi, Koichi Saeki et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 6
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Takahashi, Koichi Saeki et al.|Nature Genetics|2025Cited by 1